A Novel Substrate-Inspired Fluorescence-Based Albumin Detection Improves Assessment of Clinical Outcomes in Hemodialysis Patients Receiving a Nursing Nutrition Intervention

10 August 2021: Clinical Research

Lei You ^ABCE* , Xia Wang ^BDEG* , Wenhong Wang ^DEF*

DOI: 10.12659/MSM.930257

Med Sci Monit 2021; 27:e930257

Table 1 Clinical baseline characteristics between the 2 groups.

Parameters	IG, n=35	CG, n=33	P values
Age	48.9±10.7	47.45±11.3	0.681
Male/Female	20/15	20/13	0.772
Hemodialysis duration, years	3.52±2.06	3.37±2.52	0.321
Smoking, n (%)	7 (20.0)	8 (24.2)	0.673
Drinking, n (%)	6 (17.1)	5 (15.2)	0.824
TC (mg/dL)	169.6±23.5	161.9±25.4	0.531
HDL-C (mg/dL)	54.8±16.4	51.6±13.3	0.314
LDL-C (mg/dL)	94.5±22.1	89.5±22.6	0.273
TG (mg/dL)	114.8±26.7	110.2±23.9	0.164
CRP (μg/mL)	5.8±3.6	6.1±3.4	0.198
Adiponectin (μg/mL)	8.7±2.9	8.3±2.4	0.207
AST (IU/L)	24.8±6.7	23.2±5.9	0.185
ALT (IU/L)	18.9±4.3	19.4±5.5	0.298
Plasma creatinine (μM)	354.6±48.7	361.2±50.3	0.293
HbA1c (%)	5.8±0.5	5.7±0.6	0.592
Lipid-lowering agents, cases (%)			0.934
Statin	23 (65.7)	22 (66.7)
Fibrate	3 (8.6)	2 (6.1)
Nicotinic acid and derivatives	2 (5.7)	1 (3.0)
Anion exchange resin	2 (5.7)	3 (9.1)
Others	5 (14.3)	6 (18.2)
Antiplatelet agents, cases (%)
Cilostazol	2 (5.7)	2 (6.1)	0.819
Ticlopidine	2 (5.7)	2 (6.1)
Dipyridamole	3 (8.6)	2 (6.1)
Aspirin	24 (68.6)	25 (75.8)
Sarpogrelate	2 (5.7)	1 (3.0)
Clopidogrel	2 (5.7)	1 (3.0)
TVC, cases (%)	7 (20.0)	6 (18.2)	0.849
AVF, cases (%)	2 (5.7)	3 (9.1)	0.946
Anuric, cases (%)	9 (25.7)	11 (33.3)	0.491
Albuminuria, cases (%)	20 (57.1)	18 (54.5)	0.829
Serum protein (g/dL)	6.6±1.2	6.4±1.0	0.269
Serum albumin(g/dL)	2.9±0.6	2.8±0.7	0.351
TVC – tunneled central venous catheter; AVF – arteriovenous fistula. Chi-square was used for analyzing the statistical difference of count data and -student test was used for analyzing the statistical difference of measured data. The statistical difference was insignificant if P>0.05.